Error (ZVZZT) had the highest return between September 1, 2023 and September 8, 2023 by a US stock, returning 154.5%.
| ASSET | DATE | % RETURN |
|---|---|---|
error (ZVZZT) | 9/1/2023 - 9/8/2023 | 154.54% |
Exodus Movement (EXOD) | 9/1/2023 - 9/8/2023 | 149.64% |
TON Strategy (TONX) | 9/1/2023 - 9/8/2023 | 132% |
Greenland Acquisition (GTEC) | 9/1/2023 - 9/8/2023 | 52.03% |
Canopy Growth (CGC) | 9/1/2023 - 9/8/2023 | 47.94% |
PAVmed (PAVM) | 9/1/2023 - 9/8/2023 | 44.31% |
Journey Medical (DERM) | 9/1/2023 - 9/8/2023 | 44.04% |
GD Culture (GDC) | 9/1/2023 - 9/8/2023 | 43.12% |
Coya Therapeutics, Inc Common Stock (COYA) | 9/1/2023 - 9/8/2023 | 42.57% |
Myomo (MYO) | 9/1/2023 - 9/8/2023 | 40.96% |
Helius Medical Technologies Inc Class A (HSDT) | 9/1/2023 - 9/8/2023 | 40.09% |
Wheels Up Experience (UP) | 9/1/2023 - 9/8/2023 | 39.47% |
Kaixin Auto (KXIN) | 9/1/2023 - 9/8/2023 | 39.13% |
Shengfeng Development Limited Class A Ordinary Shares (SFWL) | 9/1/2023 - 9/8/2023 | 34.31% |
EUDA Health (EUDA) | 9/1/2023 - 9/8/2023 | 32.46% |
SUI (SUIG) | 9/1/2023 - 9/8/2023 | 31.56% |
Lantronix (LTRX) | 9/1/2023 - 9/8/2023 | 31.54% |
Entero Therapeutics (GRDX) | 9/1/2023 - 9/8/2023 | 30.5% |
Entero Therapeutics (ENTO) | 9/1/2023 - 9/8/2023 | 30.5% |
Immix Biopharma (IMMX) | 9/1/2023 - 9/8/2023 | 29.85% |
Global Interactive Technologies (GITS) | 9/1/2023 - 9/8/2023 | 29.34% |
GigaCloud Technology Inc Class A Ordinary Shares (GCT) | 9/1/2023 - 9/8/2023 | 28.63% |
VistaGen Therapeutics (VTGN) | 9/1/2023 - 9/8/2023 | 28.38% |
Iqstel (IQST) | 9/1/2023 - 9/8/2023 | 27.81% |
FingerMotion (FNGR) | 9/1/2023 - 9/8/2023 | 27.22% |
